Midtown Urology Division of Medical Research

Ongoing Research Studies

A Prospective, Multicenter Phase I/II Safety and Tolerability Study of Unilateral Vascular-Targeted Photodynamic Therapy Using WST11 in Patients with Localized Prostate Cancer

• Anticipated start date: June 2009
• Sponsor: Steba Biotech

Hypoactive Sexual Desire Disorder in Women Registry

• Ongoing since January 2009
• Sponsor: Boehringer Ingelheim Pharmaceuticals, Inc.

12 Week Randomized, Double – Blind, Double Dummy, Placebo – Controlled, Parallel – Group, Multicenter Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients With Overactive Bladder

• Ongoing since February 2008
• Sponsor: Pfizer, Inc

• Ongoing since January 2008
• Sponsor: Veridex, LLC (a Johnson & Johnson company)

A multicenter, prospective, randomized, masked, two-armed study to evaluate the safety and effectiveness of the AttenueX Intravesical System in the management of females with stress urinary incontinence

• Ongoing since May 2006
• Sponsors: Solace Therapeutics, Inc.
• Website: http://bladdercomfort.com

A phase III, randomized, double-blind, placebo controlled, multi-center efficacy and safety study of toremifene citrate for prevention of prostate cancer in men with High Grade PIN (prostatic intraepithelial neoplasia)

• Ongoing since January 2005
• Sponsor: GTx The Men’s Biotech Company

A phase III, double-blind, placebo-controlled study evaluating the effect of selenium and vitamin E alone and in combination on clinical evidence of prostate cancer

• Ongoing since October 2002
• Sponsors: National Cancer Institute and the Southwest Oncology Group